Therefore, given that serum N-MID levels were significantly associated with CRP and TG levels and the strong relationship of serum N-MID with carotid atherosclerosis risk, N-MID can be considered as a promising candidate for risk assessment and a potential intervention target for CVD. The gene discussed is CRP; the disease is carotid atherosclerosis.